本月蛋白精選 | 覆蓋多領(lǐng)域研究需求，優(yōu)選好物不容錯(cuò)過
本期云克隆精選重組蛋白、活性蛋白、熱門靶點(diǎn)蛋白三大核心品類，全面覆蓋分子互作分析、細(xì)胞功能實(shí)驗(yàn)、藥物高通量篩選等關(guān)鍵研究場(chǎng)景，為你的科研項(xiàng)目提供精準(zhǔn)支撐。所有產(chǎn)品均遵循頂刊同款制備配方，或經(jīng)權(quán)威實(shí)驗(yàn)室多輪嚴(yán)格驗(yàn)證，溯源可查、數(shù)據(jù)精準(zhǔn)，從源頭規(guī)避實(shí)驗(yàn)變量。
選擇云克隆優(yōu)質(zhì)蛋白，幫你跳過反復(fù)試錯(cuò)的耗時(shí)環(huán)節(jié)，降低實(shí)驗(yàn)不確定性，讓科研進(jìn)程更高效、成果產(chǎn)出更穩(wěn)健，加速論文發(fā)表之路。云克隆愿以可靠品質(zhì)，陪伴每一位科研人，穩(wěn)步探索生命科學(xué)的未知疆界。
01 C4B、C8B
產(chǎn)品貨號(hào)：RPB305Hu01
產(chǎn)品名稱：補(bǔ)體4B(C4B)重組蛋白
文獻(xiàn)名稱：Evolution of Multivalent Aptamer Corona for High-Throughput Multiplexed Detection of Multiple Cancers
雜志名稱：Advanced Science
影響因子：14.1
PMID/DOI：41290548
發(fā)表日期： 11/25/2025
發(fā)表單位：天津大學(xué)生命科學(xué)院
樣本類型：結(jié)直腸癌特異性適配體8號(hào)、9號(hào)
應(yīng)用類型：表面等離子體共振（SPR）
02 SPON2
產(chǎn)品貨號(hào)：RPF396Mu01
產(chǎn)品名稱：脊椎蛋白2(SPON2)重組蛋白
文獻(xiàn)名稱：Downregulation of the biological macromolecule Spondin-2 disrupts maternal-fetal immune tolerance and trophoblast invasion, driving unexplained recurrent pregnancy loss
雜志名稱：International Journal of Biological Macromolecules
影響因子：8.5
PMID/DOI：41391791
發(fā)表日期： 12/12/2025
發(fā)表單位：西安交通大學(xué)第二附屬醫(yī)院婦產(chǎn)科
樣本類型：易流產(chǎn)妊娠模型小鼠
應(yīng)用類型：動(dòng)物注射
Figure 8. SPON2 supplementation improves pregnancy outcomes in the abortion-prone mouse model. A) Schematic diagram of the animal experimental protocol. B) Representative protein band and quantification of SPON2 expression in mice placentas from NP group, AP group and drug treatment group (each group: n=3).
03 AMPKa1
產(chǎn)品貨號(hào)：RPA679Hu02
產(chǎn)品名稱：AMP激活蛋白激酶α1(AMPK Alpha 1)重組蛋白
文獻(xiàn)名稱：Baicalin attenuates pulmonary hypertension by targeting AMPK/CPT1A-mediated fatty acid metabolism
雜志名稱：Phytomedicine
影響因子：8.3
PMID/DOI：41447844
發(fā)表日期： 12/8/2025
發(fā)表單位：廣東醫(yī)科大學(xué)附屬醫(yī)院
樣本類型：黃芩苷（分子式C21H18O11）
應(yīng)用類型：表面等離子體共振（SPR）
Figure 8. Molecular interaction between baicalin and AMPKα1.(C)Surface plasmon resonance (SPR) sensogram validating direct binding (KD= 8.74 × 10?? M).
04 IFNb、IL2
產(chǎn)品貨號(hào)：EPA222Mu61
產(chǎn)品名稱：干擾素β(IFNb)真核蛋白
文獻(xiàn)名稱：IFNβ?pSTAT1-IRF1 axis controls colorectal tumor development through induction of immunogenic Ly6C+myeloid cells
雜志名稱：Neoplasia
影響因子：7.7
PMID/DOI：41344265
發(fā)表日期： 12/3/2025
發(fā)表單位：天津大學(xué)生命科學(xué)院
樣本類型：RAW264.7小鼠單核巨噬細(xì)胞白血病細(xì)胞系，J774A.1小鼠單核巨噬細(xì)胞細(xì)胞系
應(yīng)用類型：細(xì)胞培養(yǎng)
Figure S1. IFNβ induces myeloid cells to differentiate into Ly6C+ myeloid cells in mouse model. A. Establishment of cuomIFNβ overexpressing RAW264.7 cell line confirmed by qPCR (top; n=3) and qRT-PCR (bottom) with β-actin as internal control. B-D. RAW264.7 cells overexpressing cuomIFNβ (B), as well as RAW264.7(C) and J774M(D) cells treated with mIFNβ were analyzed for percentages of Ly6C+ myeloid cells (CD11b+Ly6C+Ly6G-) by flow cytometry (n=3).
產(chǎn)品貨號(hào)：APA073Hu61；APA222Hu01
產(chǎn)品名稱：白介素2(IL2)活性蛋白；干擾素β(IFNb)活性蛋白
樣本類型：人外周血單個(gè)核細(xì)胞（PBMCs）
應(yīng)用類型：細(xì)胞培養(yǎng)
IFNβ induces myeloid cells to differentiate into Ly6C+ myeloid cells and Monocyte antigen presentation. A. Gating strategy for monocytes (CD14+CD33+) from human PBMCs by flow cytometry. B-D. The percentage of monocytes (CD14+CD33+) in human PBMCs treated with human interferon-β (100 ng/mL, 24 hours) under unstimulated (B), IL-2-stimulated (C), or anti-human CD3-stimulated (D) conditions (n = 5).
05 ESM1
產(chǎn)品貨號(hào)：RPC463Mu01
產(chǎn)品名稱：內(nèi)皮細(xì)胞特異分子1(ESM1)重組蛋白
文獻(xiàn)名稱：Neutralizing endocan reduces blood pressure and improves endothelial function in angiotensin II-induced hypertensive mice
雜志名稱：Biomedicine & Pharmacotherapy
影響因子：7.5
PMID/DOI：41418665
發(fā)表日期： 12/18/2025
發(fā)表單位：韓國(guó)首爾延世大學(xué)醫(yī)學(xué)院生理學(xué)系
樣本類型：C57BL/6小鼠
應(yīng)用類型：動(dòng)物注射
樣本類型：人臍靜脈內(nèi)皮細(xì)胞（HUVECs）
應(yīng)用類型：細(xì)胞培養(yǎng)
